Slade & Baker Vision Center is constantly being sought out by device and pharmaceutical companies to conduct clinical trials to help them gain FDA approval. Often, patients who are eligible for these clinical trials receive significant discounts for their participation. Current clinical trials being conducted at Slade & Baker Vision Center are listed below. Please call our office to learn more.

T-CAT Study

This LASIK study is for patients who are nearsighted or farsighted or have astigmatism. In this study we use a new, custom LASIK treatment pattern. The treatment pattern is approved in Europe and we are assisting in gaining its approval in the US.Early results are impressive. A significant reduction in the cost for LASIK is provided to patients for their participation. Qualifying patients must be 18 years of age or older.

Presbylens

Presbylens is a unique treatment for presbyopia, loss of near vision with age, which typically happens to everyone over 40 years of age. The Presbylens is a microscopic clear lens that is implanted in the cornea of the eye. A small LASIK like flap is made with a laser; the Presbylens is laid on the cornea under the flap; and the corneal flap is returned to its original position where it bonds without stitches. No corneal tissue is removed and the lens is removable if needed. This technique is approved in Europe and we are assisting in gaining its approval in the US. For patients who qualify for the Presbylens, the surgery will be performed at no charge.

Bacterial Conjunctivitis

This study is for patients with red or infected eyes. Patients must be at least 1 year of age or older and have a clinical diagnosis of acute bacterial conjunctivitis.If they wear contact lenses, participants must be willing to discontinue contact lens wear for the duration of the study for several weeks.

Ketorolac/ICL

This is a study of a drug that is already approved in the US, to determine its effectiveness at reducing inflammation in the eye for patients having an ICL, or Implantable Contact Lens. The ICL is a tiny clear lens (similar to a soft contact lens) that is inserted into the front part of the eye. The ICL is typically used for patients that have higher levels of nearsightedness or who are poor candidates for LASIK or PRK. The ICL is also fully approved in the US. For qualifying patients, there is a significant reduction in the cost of the surgery. Qualifying patients must be at least 18 years of age or older.